You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

GO5R2

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Brodalumab in Plaque Psoriasis to Understand Impact on Quality

Recruiting
  • Psoriasis
  • Brodalumab
  • Matched cohort
  • Calgary, Alberta, Canada
  • +33 more
Oct 8, 2022

Vasovagal Syncope Trial in Canada, Poland, United States (midodrine HCl, matching )

Active, not recruiting
  • Vasovagal Syncope
  • midodrine hydrochloride
  • matching placebo
  • Minneapolis, Minnesota
  • +16 more
Nov 1, 2022

Breast Cancer Trial in Worldwide (Ribociclib, Letrozole or Anastrozole, Goserelin)

Active, not recruiting
  • Breast Cancer
  • Mobile, Alabama
  • +90 more
Dec 19, 2022

Type 2 Diabetes, Obesity Trial in Worldwide (Tirzepatide, Placebo)

Not yet recruiting
  • Type 2 Diabetes
  • Obesity
  • Caba, Buenos Aires, Argentina
  • +48 more
Sep 8, 2023

Psychiatric Illness Trial in Edmonton, Fort McMurray, Calgary (Text4Support, Peer support)

Recruiting
  • Psychiatric Illness
  • Text4Support
  • Peer support
  • Edmonton, Alberta, Canada
  • +6 more
Apr 3, 2022

Above Optimal Plasma LDL Concentrations Trial in Winnipeg, Toronto (muffin)

Active, not recruiting
  • Above Optimal Plasma LDL Concentrations
  • muffin
  • Winnipeg, Manitoba, Canada
  • +1 more
Oct 24, 2022

Asthma Trial in Edegem (Test product (T):CHF 5993 BDP/FF/GB 200/6/12.5 µg pMDI, Reference product 1 (R1): CHF 5993 BDP/FF/GB

Recruiting
  • Asthma
  • Test product (T):CHF 5993 BDP/FF/GB 200/6/12.5 µg pMDI
  • +2 more
  • Edegem, Antwerpen, Belgium
    SGS Belgium NV - Clinical Pharmacology Unit
Jun 1, 2023

Non-melanoma Skin Cancer, Carcinoma, Squamous Cell, Carcinoma, Basal Cell Trial in Canada (Nicotinamide, Placebo)

Not yet recruiting
  • Non-melanoma Skin Cancer
  • +3 more
  • Calgary, Alberta, Canada
  • +7 more
Jul 13, 2023

Prostate Cancer Trial in Vancouver, Toronto, Montréal (Survivorship Care Plan)

Active, not recruiting
  • Prostate Cancer
  • Survivorship Care Plan
  • Vancouver, British Columbia, Canada
  • +2 more
Nov 14, 2022

Hip Osteoarthritis Trial in Winnipeg, London (ACTIS)

Recruiting
  • Hip Osteoarthritis
  • ACTIS
  • Winnipeg, Manitoba, Canada
  • +2 more
Nov 1, 2022

Cystic Fibrosis Pulmonary Exacerbation Trial in Canada (Prednisone, Placebos)

Recruiting
  • Cystic Fibrosis Pulmonary Exacerbation
  • Calgary, Alberta, Canada
  • +11 more
Nov 23, 2022

Disease Activity in Canadian Adult Moderate-to-Severe Atopic

Recruiting
  • Atopic Dermatitis
    • Calgary, Alberta, Canada
    • +17 more
    Jan 17, 2023

    AL Amyloidosis Trial in United States (Bortezomib, Cyclophosphamide, Dexamethasone)

    Recruiting
    • AL Amyloidosis
    • Orange, California
    • +5 more
    May 3, 2022

    Opioid Use Disorder Trial in New Haven (NYX-783, Placebo, Oxycodone)

    Not yet recruiting
    • Opioid Use Disorder
    • New Haven, Connecticut
    • +1 more
    Dec 2, 2022

    Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Trial in Victoria (5:2 Method (intermittent fasting

    Enrolling by invitation
    • Chronic Lymphocytic Leukemia (CLL)
    • Small Lymphocytic Lymphoma (SLL)
    • 5:2 Method (intermittent fasting regimen)
    • 16/8 Method (intermittent fast regimen)
    • Victoria, British Columbia, Canada
      Eleah Stringer
    Feb 2, 2023

    Implementation of Personalized Medicine for Optimal Drug Therapy

    Not yet recruiting
    • Nausea With Vomiting Chemotherapy-Induced
    • +2 more
    • Pharmacogenetic testing
    • Drug-Drug interaction analysis
    • London, Ontario, Canada
      Lawson Health Research Institute
    Apr 13, 2023

    Breast-Conserving Surgery Alone in Low-Risk Ductal Carcinoma in

    Recruiting
    • DCIS
      • Victoria, British Columbia, Canada
      • +9 more
      Jan 31, 2023

      Type II Diabetes Trial (T1: FDC 5/500 mg; R1+R: SHR3824 5 mg + Metformin 500 mg XR, T2: FDC 5/1000 mg; R2+R: SHR3824 5 mg + two

      Not yet recruiting
      • Type II Diabetes
      • T1: FDC 5/500 mg; R1+R: SHR3824 5 mg + Metformin 500 mg XR
      • T2: FDC 5/1000 mg; R2+R: SHR3824 5 mg + two Metformin 500 mg XR
      • (no location specified)
      Nov 3, 2021

      Diabetes Type 2 Trial (Behavioral and drugs already approved and available for diabetes management)

      Recruiting
      • Diabetes Type 2
      • Behavioral and drugs already approved and available for diabetes management
      • Portage La Prairie, Manitoba, Canada
        Portage Clinic
      Nov 14, 2022

      Healthy Trial in Nottingham (BI 685509 oral formulation prototypes, BI 685509 standard oral formulation)

      Completed
      • Healthy
      • R1: Reference Product X
      • +12 more
      • Nottingham, United Kingdom
        Quotient Sciences
      Dec 7, 2022

      Stroke, Cerebral Infarction, Brain Diseases Trial in Canada (Arm Boot Camp)

      Completed
      • Stroke
      • +10 more
      • Arm Boot Camp
      • Calgary, Alberta, Canada
      • +6 more
      Feb 1, 2023

      Oropharyngeal Cancer Trial in Canada (Radiation, Cisplatin)

      Active, not recruiting
      • Oropharyngeal Cancer
      • Prince George, British Columbia, Canada
      • +13 more
      Dec 12, 2022

      Multiple Myeloma Trial in Worldwide (Cevostamab, Tocilizumab)

      Recruiting
      • Multiple Myeloma
      • Birmingham, Alabama
      • +17 more
      Jan 23, 2023

      Infection Trial in Canada (Fecal Microbiota Transplantation (FMT))

      Suspended
      • Infection
      • Fecal Microbiota Transplantation (FMT)
      • Brampton, Ontario, Canada
      • +12 more
      Nov 1, 2022

      Local Recurrence Following Breast Conserving Surgery and

      Active, not recruiting
      • Breast Cancer
        • Calgary, Alberta, Canada
        • +26 more
        Sep 19, 2022